Phytochemical Name : Aglaiabbreviatin E (AA-5)

Properties Information
PhytoCAT-ID PhytoCAT-581
Phytochemical name or plant extracts Aglaiabbreviatin E (AA-5)
PMID 29050217
Literature evidence After 48 h treatment, AA-5 (1) and AA-6 (2) significantly increased mitochondrial-mediated apoptosis by enhancing reactive oxygen species (ROS) with depressed mitochondrial membrane potential and caspase-9 activities.
IUPAC name (5R,8R,9R,10R,13R,14R,17S)-17-[(4E)-6-hydroxy-6-methylhepta-1,4-dien-2-yl]-4,4,8,10,14-pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
Phytochemicals’ class or type of plant extracts Triterpenoid
Source of phytochemicals or plant Extracts Aglaia abbreviata
Geographical availability Andaman Is., Assam, Bangladesh, Borneo, Cambodia, China South-Central, China Southeast, Hainan, India, Jawa, Laos, Lesser Sunda Is., Malaya, Maluku, New Caledonia, New Guinea, Philippines, Queensland, Samoa, Sri Lanka, Sulawesi, Sumatera, Taiwan, Thailand, Vanuatu, Vietnam, Western Australia
Plant parts Stem
Other cancers Breast cancer
Target gene or protein Caspase 9
Gene or Protein evidence After 48 h treatment, AA-5 (1) and AA-6 (2) significantly increased mitochondrial-mediated apoptosis by enhancing reactive oxygen species (ROS) with depressed mitochondrial membrane potential and caspase-9 activities.
Target pathways Akt pathway
IC50 14.80 µM against MCF-7 10.22 µM against MCF-7/ADM
Potency Therefore, AA-5 (1) and AA-6 (2) may be effective anti-tumor and reversal agents for the further development of therapeutics against MDR breast cancer.
Cell line/ mice model MCF-7, MCF-7/ADM
Additional information  Therefore, AA-5 (1) and AA-6 (2) may be effective anti-tumor and reversal agents for the further development of therapeutics against MDR breast cancer.
PubChem ID 50908449
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:577065-1
Safety NA